IOVANCE BIOTHERAPEUTICS, INC. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit: ratio: %
Description: Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary: Iovance Biotherapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
Iovance Biotherapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -45.5 %, a 18.6% increase year-over-year.
Iovance Biotherapeutics, Inc. annual Return On Assets for 2023 was -55.3 %, a 12% increase from 2022.
Iovance Biotherapeutics, Inc. annual Return On Assets for 2022 was -62.8 %, a 47.2% decline from 2021.
Iovance Biotherapeutics, Inc. annual Return On Assets for 2021 was -42.7 %, a 9.13% decline from 2020.

Return On Assets, Quarterly (%)

Return On Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q3 2024	-45.5	+10.4	+18.6%	Jul 1, 2024	Sep 30, 2024
Q2 2024	-50.8	+9.21	+15.3%	Apr 1, 2024	Jun 30, 2024
Q1 2024	-55.2	+7.07	+11.4%	Jan 1, 2024	Mar 31, 2024
Q4 2023	-55.3	+7.54	+12%	Oct 1, 2023	Dec 31, 2023
Q3 2023	-55.9	+3.28	+5.54%	Jul 1, 2023	Sep 30, 2023
Q2 2023	-60	-8.41	-16.3%	Apr 1, 2023	Jun 30, 2023
Q1 2023	-62.2	-16.9	-37.2%	Jan 1, 2023	Mar 31, 2023
Q4 2022	-62.8	-20.1	-47.2%	Oct 1, 2022	Dec 31, 2022
Q3 2022	-59.2	-20.3	-52.1%	Jul 1, 2022	Sep 30, 2022
Q2 2022	-51.6	-15.6	-43.4%	Apr 1, 2022	Jun 30, 2022
Q1 2022	-45.4	-11.3	-33.3%	Jan 1, 2022	Mar 31, 2022
Q4 2021	-42.7	-3.57	-9.13%	Oct 1, 2021	Dec 31, 2021
Q3 2021	-38.9	+6.73	+14.7%	Jul 1, 2021	Sep 30, 2021
Q2 2021	-36	+17.2	+32.4%	Apr 1, 2021	Jun 30, 2021
Q1 2021	-34	+28.8	+45.9%	Jan 1, 2021	Mar 31, 2021
Q4 2020	-39.1	+9.16	+19%	Oct 1, 2020	Dec 31, 2020
Q3 2020	-45.6	-8.08	-21.5%	Jul 1, 2020	Sep 30, 2020
Q2 2020	-53.2	-16.6	-45.4%	Apr 1, 2020	Jun 30, 2020
Q1 2020	-62.9	-27.1	-75.7%	Jan 1, 2020	Mar 31, 2020
Q4 2019	-48.3	-11.5	-31.2%	Oct 1, 2019	Dec 31, 2019
Q3 2019	-37.6	+8.35	+18.2%	Jul 1, 2019	Sep 30, 2019
Q2 2019	-36.6	+9.06	+19.8%	Apr 1, 2019	Jun 30, 2019
Q1 2019	-35.8	+14.8	+29.2%	Jan 1, 2019	Mar 31, 2019
Q4 2018	-36.8	+22.4	+37.8%	Oct 1, 2018	Dec 31, 2018
Q3 2018	-45.9	+5.34	+10.4%	Jul 1, 2018	Sep 30, 2018
Q2 2018	-45.7	+33.4	+42.2%	Apr 1, 2018	Jun 30, 2018
Q1 2018	-50.6	+15.5	+23.5%	Jan 1, 2018	Mar 31, 2018
Q4 2017	-59.1	+3.99	+6.32%	Oct 1, 2017	Dec 31, 2017
Q3 2017	-51.3	+14	+21.5%	Jul 1, 2017	Sep 30, 2017
Q2 2017	-79	-52.1	-194%	Apr 1, 2017	Jun 30, 2017
Q1 2017	-66.1	-39.1	-145%	Jan 1, 2017	Mar 31, 2017
Q4 2016	-63.1	-38.3	-155%	Oct 1, 2016	Dec 31, 2016
Q3 2016	-65.3	-40.5	-164%	Jul 1, 2016	Sep 30, 2016
Q2 2016	-26.9	-0.44	-1.66%	Apr 1, 2016	Jun 30, 2016
Q1 2016	-27	+3.77	+12.3%	Jan 1, 2016	Mar 31, 2016
Q4 2015	-24.8	+23.1	+48.2%	Oct 1, 2015	Dec 31, 2015
Q3 2015	-24.8	+77.4	+75.8%	Jul 1, 2015	Sep 30, 2015
Q2 2015	-26.5	+18.5	+41.1%	Apr 1, 2015	Jun 30, 2015
Q1 2015	-30.8	+20.6	+40.1%	Jan 1, 2015	Mar 31, 2015
Q4 2014	-47.9	+5.8	+10.8%	Oct 1, 2014	Dec 31, 2014
Q3 2014	-102	-77.6	-315%	Jul 1, 2014	Sep 30, 2014
Q2 2014	-44.9	+939	+95.4%	Apr 1, 2014	Jun 30, 2014
Q1 2014	-51.4	-3.78K	-101%	Jan 1, 2014	Mar 31, 2014
Q4 2013	-53.7	+6.54K	+99.2%	Oct 1, 2013	Dec 31, 2013
Q3 2013	-24.6	+8.16K	+99.7%	Jul 1, 2013	Sep 30, 2013
Q2 2013	-984	+970	+49.6%	Apr 1, 2013	Jun 30, 2013
Q1 2013	3.73K	+6.45K		Jan 1, 2013	Mar 31, 2013
Q4 2012	-6.6K			Oct 1, 2012	Dec 31, 2012
Q3 2012	-8.18K			Jul 1, 2012	Sep 30, 2012
Q2 2012	-1.95K			Apr 1, 2012	Jun 30, 2012
Q1 2012	-2.72K			Jan 1, 2012	Mar 31, 2012

* An asterisk sign (*) next to the value indicates that the value is likely invalid.